New SRM Data Dependent Exclusion (MS)^n Measurement for Structural Determination of Drug Metabolites Using LC/ESI/Ion Trap MS
スポンサーリンク
概要
- 論文の詳細を見る
- 2003-12-25
著者
-
Kawamura A
Pharmacokinetic Research Laboratories Fujisawa Pharmaceutical Co. Ltd.:(present Address)analysis And
-
Shirage Toshifumi
Departmnet Of Pharmacolinetics And Drug Metabolism Pharma Ceutical And Pharmacolinetic Research Labo
-
Shiraga T
Biopharmaceutical And Pharmacokinetic Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Niwa T
近畿大学 薬学部
-
NIWA Toshiro
Biopharmaceutical and Pharmacokinetic Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
SHIRAGA Toshifumi
Biopharmaceutical and Pharmacokinetic Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
KAGAYAMA Akira
Biopharmaceutical and Pharmacokinetic Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
TOZUKA Zenzaburo
Biopharmaceutical and Pharmacokinetic Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
KAWAMURA Akio
Biopharmaceutical and Pharmacokinetic Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
KANEKO Hayato
Biopharmaceutical and Pharmacokinetics Research Laboratories Fujisawa Pharmaceutical Co., Ltd.
-
BEPPU Manabu
Biopharmaceutical and Pharmacokinetics Research Laboratories Fujisawa Pharmaceutical Co., Ltd.
-
Tozuka Zenzaburo
Biopharmaceutical And Pharmacokinetics Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Niwa T
Post-marketing Development Research Center Fujisawa Pharmaceutical Co. Ltd.
-
Beppu Manabu
Biopharmaceutical And Pharmacokinetics Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Kaneko Hayato
Biopharmaceutical And Pharmacokinetics Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Kagayama Akira
Biopharmaceutical And Pharmacokinetic Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Shiraga Toshifumi
Biopharmaceutical And Pharmacokinetic Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Niwa Toshiro
Post Marketing Product Development Astellas Pharma Inc.
-
Kawamura Akio
Department Of Surgery Sapporo Hokuyu Hospital Research Institute For Artificial Organs Transplantati
関連論文
- Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs
- No-needle blood access device for hemodialysis and no-needle connecting cannula assembly (K-NOBA PAT./JAP2983540)
- Molecular Cloning, Expression, and Enzymatic Characterization of Rabbit Hydroxysteroid Sulfotransferase AST-RB2 (ST2A8)^1
- Molecular Cloning and Expression of an Amine Sulfotransferase cDNA: A New Gene Family of Cytosolic Sulfotransferases in Mammals^1
- Effects of Serotonin-3 Receptor Antagonists on Cytochrome P450 Activities in Human Liver Microsomes(Biopharmacy)
- Contribution of Human Hepatic Cytochrome P450 Isoforms to the Metabolism of Psychotropic Drugs(Biopharmacy)
- Interindividual Variability in 5-Fluorouracil Metabolism and Procainamide N-Acetylation in Human Liver Cytosol(Biochemistry/Molecular Biology)
- LTQ FT MS Accurate Mass and SRM Data Dependent Exclusion MSn Measurements for Structure Determination of FK228 and Its Metabolites (BMS特集号)
- Identification of Cytochrome P450 Enzymes Involved in the Metabolism of FK228, a Potent Histone Deacetylase Inhibitor, in Human Liver Microsomes(Biopharmacy)
- Interindividual Variability in 2-Hydroxylation, 3-Sulfation, and 3-Glucuronidation of Ethynylestradiol in Human Liver(Biochemistry/Molecular Biology)
- Effect of Nilvadipine, a Dihydropyridine Calcium Antagonist, on Cytochrome P450 Activities in Human Hepatic Microsomes (Biochemistry/Molecular Biology)
- Effect of Cefixime and Cefdinir, Oral Cephalosporins, on Cytochrome P450 Activities in Human Hepatic Microsomes(Biochemistry/Molecular Biology)
- New SRM Data Dependent Exclusion (MS)^n Measurement for Structural Determination of Drug Metabolites Using LC/ESI/Ion Trap MS
- Stategy for Structure Elucidation of Drug Metabolites Derived from Protonated Molecules and (MS)^n Fragmentation of Zotepine, Tiaramide and their Metabolites
- Penetration and Absorption of Tacrolimus (FK506) Ointment in the Skin After a Single Dermal Application to the Rat
- Oxidative Metabolism of Tacrolimus and its Metabolite by Human Cytochrome P450 3A Subfamily
- Pharmacokinetics of Tacrolimus (FK506) Ointment after a Single Dermal Application to the Rat
- Absorption, Distribution and Excretion of ^C-labeled Tacrolimus (FK506) Ointment after a Single Dermal Application to the Rat
- Absorption, Distribution and Excretion of Tacrolimus (FK506) in the Baboon
- Absorption, Distribution, Metabolism and Excretion of Tacrolimus (FK506) in the Rat
- Comparison of Tacrolimus (FK506) Levels Determined by Three Different Methods in the Rat Blood
- Effect of Antifungal Drugs on Cytochrome P450 (CYP) 1A2, CYP2D6, and CYP2E1 Activities in Human Liver Microsomes(Biopharmacy)
- Effect of Antifungal Drugs on Cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 Activities in Human Liver Microsomes(Biopharmacy)
- No Inhibition of Cytochrome P450 Activities in Human Liver Microsomes by Sulpiride, an Antipsychotic Drug(Biopharmacy)
- Tissue Distribution after Intravenous Dosing of Micafungin, an Antifungal Drug, to Rats(Biopharmacy)
- Metabolism of Tacrolimus (FK506) and its Metabolite by Rat Liver Microsomes
- Inhibition of Human Hepatic Cytochrome P450s and Steroidogenic CYP17 by Nonylphenol
- Metabolism and Interaction of Bisphenol A in Human Hepatic Cytochrome P450 and Steroidogenic CYP17
- Inhibition of Drug-Metabolizing Enzyme Activity in Human Hepatic Cytochrome P450s by Bisphenol A
- Transient increase in telomerase activity of proliferating fibroblasts and endothelial cells in granulation tissue of the human skin
- Adenocarcinoma arising in gastric heterotopic pancreas : Clinicopathological and immunohistochemical study with genetic analysis of a case
- Evidence for Singlet Oxygen Involvement in Rat and Human Cytochrome P450-dependent Substrate Oxidations
- Utility of Microtiter Plate Assays for Human Cytochrome P450 Inhibition Studies in Drug Discovery : Application of Simple Method for Detecting Quasi-irreversible and Irreversible Inhibitors
- Further accumulation of Cd in renal cellular membranes caused by administration of desferrioxamine to Cd-burdened rats
- Artificial liver support at present and in the future
- Problems of double-lumen catheter used for blood purification and their improvement